PLA2R1 and nephrotic syndrome: The new score is based on eGFR, serum albumin, urinary protein excretion, proteinuria selectivity index, serum anti-PLA2R concentration, urinary levels of specific proteins (α1-microglobulin, β2-microglobulin, IgG) and the presence of severe and potentially life-threatening nephrotic syndrome complications.